Blake Borgeson

Director, Recursion Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.3M

Companies

Latest trade

Oct 6, 2026

Companies

Recursion Pharmaceuticals, Inc.Director −$4.3M

Trades

RXRX Sold 50,000 shares at $4.84 · planned $0.2M Oct 6

RXRX Sold 30,000 shares at $3.34 · planned $0.1M Sep 1

RXRX Sold 30,000 shares at $3.25 · planned $0.1M Aug 4

RXRX Sold 40,000 shares at $3.96 · planned $0.2M Jul 7

RXRX Sold 30,000 shares at $3.68 · planned $0.1M Jun 2

RXRX Sold 30,000 shares at $3.52 · planned $0.1M May 5

RXRX Sold 30,000 shares at $3.10 · planned $0.1M Apr 7

RXRX Sold 170,000 shares at $3.46 · planned $0.6M Mar 3

RXRX Sold 220,000 shares at $4.20 · planned $0.9M Feb 3

RXRX Sold 220,000 shares at $4.36 · planned $1.0M Jan 6

RXRX Sold 220,000 shares at $4.37 · planned $1.0M Dec 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.